Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma
Authors:
- Shuichi KanekoSKShuichi Kaneko
- Yasunari NakamotoYNYasunari Nakamoto
- Takashi KagayaTKTakashi Kagaya
- Naofumi MukaidaNaofumi Mukaida
- Kenichi KobayashiKKKenichi Kobayashi
- 1 October 2001
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 8 (10) , 695-704
Abstract
The therapeutic efficacy of herpes simplex virus thymidine kinase/ganciclovir (HSV-tk/GCV) system in many types of tumors is unsatisfactory due to the insufficient spread of gene transfer and insufficient cell killing. In the current study, we investigated whether adenovirally delivered monocyte chemoattractant protein (MCP)-1 potentiates the antitumor effects of the HSV-tk/GCV system in hepatocellular carcinoma (HCC) cells. Subcutaneous tumor foci of the human HCC cell line, HuH7, established in athymic mice were directly transduced with a recombinant adenovirus (rAd) harboring an HSV-tk gene driven by a human alpha-fetoprotein promoter, followed by GCV administration. Subsequently, another rAd expressing MCP-1 under the universal CAG promoter was injected. The growth of tumors was markedly suppressed by codelivering HSV-tk and MCP-1 genes compared to that by either HSV-tk/GCV or MCP-1 delivery. In the tumor tissues, monocyte/macrophage infiltration was detected immunohistochemically. The antitumor effects of the rAd expressing MCP-1 were markedly reduced by the administration of carrageenan, a compound known to inactivate macrophage. These results indicate that adenovirally delivered MCP-1 enhanced the antitumor effects of the HSV-tk/GCV system synergistically by recruitment/activation of macrophages in tumor tissues, suggesting an effective immunotherapy for HCC and other lineages of tumors when used adjuvantly with a suicide gene.Keywords
This publication has 38 references indexed in Scilit:
- The monocyte chemotactic protein a (MCP-1) and interleukin 8 (IL-8) in Hodgkin's disease and in solid tumours.Molecular Pathology, 1998
- Enhanced and Specific Gene Expression via Tissue-Specific Production of Cre Recombinase Using Adenovirus VectorBiochemical and Biophysical Research Communications, 1998
- A “Distant” Bystander Effect of Suicide Gene Therapy: Regression of Nontransduced Tumors Together with a Distant Transduced TumorHuman Gene Therapy, 1997
- Treatment of hepatocellular carcinomaJournal of Viral Hepatitis, 1997
- Construction of retroviral vectors to induce strong hepatoma cell‐specific expression of cytokine genesJournal of Gastroenterology and Hepatology, 1996
- Microwave coagulation therapy for hepatocellular carcinomaGastroenterology, 1996
- Cure of Mice with Established Metastatic Friend Leukemia Cell Tumors by a Combined Therapy with Tumor Cells Expressing Both Interferon- α 1 and Herpes Simplex Thymidine Kinase Followed by GanciclovirHuman Gene Therapy, 1996
- The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cellsCancer Letters, 1995
- Bystander Tumoricidal Effect in the Treatment of Experimental Brain TumorsNeurosurgery, 1994
- Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line.Journal of Experimental Medicine, 1989